Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

AI vs. human touch: which rehab wins for back pain?

NCT ID NCT07749833

Disease control Sponsor: Cairo University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 06, 2026 · Last updated Aug 07, 2026 · Updated 1 time

Summary

This study tests whether an artificial intelligence-driven rehabilitation program can improve outcomes for people with chronic low back dysfunction compared to a standard physical therapy program. Participants will be randomly assigned to either the AI-guided program, which personalizes exercises and provides real-time feedback, or a traditional therapy protocol. The trial will measure pain intensity, functional disability, and quality of life to see if AI can offer a more effective or efficient path to recovery.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
AI-driven personalized rehabilitation program
What this could lead to
If effective, AI-guided physical therapy could offer a more personalized, accessible, and cost-effective way to manage chronic low back pain, potentially improving outcomes and reducing healthcare burdens.
What could go wrong
This is a relatively small trial, and the AI program's success depends on user adherence and technology reliability. Results may not generalize to all patients or settings, and the AI approach may not prove superior to traditional therapy.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 68 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Aug 2026

An estimate. Start dates often move.

Expected to finish

Jan 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 45 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adults aged 18-45 years. * Male or female participants. * Clinical diagnosis of low back dysfunction by a physiotherapist or physician. * Symptoms lasting more than 3 months. * Ability to participate in physical therapy or use AI-based rehabilitation tools. * Willingness to comply with the study protocol and provide written informed consent. Exclusion Criteria: * Recent spinal injury or spinal surgery. * Previous spinal surgery within the last 6 months. * Severe neurological disorders (e.g., multiple sclerosis or Parkinson's disease). * Chronic conditions that significantly limit mobility (e.g., advanced arthritis). * Current use of strong opioid analgesics. * Severe psychiatric disorders. * Inability to use or access the required technology for the AI intervention.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Low back dysfunction are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Low Back Pain

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Low back dysfunction Low back pain

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Faculty of Physical Therapy, Cairo University

    Cairo, Cairo Governorate, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.